GYRE Gyre Therapeutics, Inc. - Common Stock
$6,80
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 7, 2026
Rango 52S
$5–$9
34% of range
Calificación del Analista
BUY
9 analysts
Precio Objetivo
$19
+175% upside
P/E (TTM)
340.0
ROE
11.7%
Margen de Beneficio Neto
8.5%
GYRE Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.80
Capitalización Bursátil
$621M
P/E (TTM)
340.0
BPA (TTM)
$0.02
Ingresos (TTM)
$117M
Rendimiento div.
—
ROE
11.7%
Deuda/Capital
—
Rango 52S
$5 – $9
GYRE Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$117M
2017-12-31
→
2025-12-31
BPA
$0.02
2021-12-31
→
2025-12-31
Flujo de caja libre
$-180.0K
2016-12-31
→
2025-12-31
Márgenes
8.5%
2023-12-31
→
2024-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
GYRE
Mediana de Pares
P/E (TTM)
340.0
19.6
P/S (TTM) (P/V (TTM))
5.3
6.4
P/B (P/C)
5.9
2.6
Price / FCF (Precio / FCF)
-3449.6
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
GYRE
Mediana de Pares
Operating Margin (Margen Operativo)
9.8%
—
Net Profit Margin (Margen de Beneficio Neto)
8.5%
-104.2%
ROA
6.8%
-40.3%
ROE
11.7%
-42.4%
ROIC
7.4%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
GYRE
Mediana de Pares
Current Ratio (Ratio corriente)
5.6
5.4
Quick Ratio (Ratio Rápido)
4.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
GYRE
Mediana de Pares
Revenue YoY (Ingresos interanuales)
10.2%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
4.5%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
41.0%
—
EPS YoY (EPS interanual)
-60.0%
—
Net Income YoY (Beneficio Neto interanual)
-44.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
GYRE
Mediana de Pares
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo
—
Ratio de Pago
—
CAGR de Dividendos a 5 años
—
| Fecha ex-dividendo | Monto |
|---|---|
| 13 de enero de 2023 | $3,6000 |
| 21 de septiembre de 2022 | $21,4500 |
| 20 de agosto de 2015 | $896,1750 |
GYRE Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
9 analistas
- Compra fuerte 3 33,3%
- Compra 5 55,6%
- Mantener 1 11,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
3 analistas · 2026-08-14
Mediana
$18.00
Media
$18.67
← Por Debajo de Todos los Objetivos
$6.80
Mín
$18.00
Máx
$20.00
Objetivo mediano
$18.00
+164,7%
Objetivo medio
$18.67
+174,5%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.01%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.12 | $-0.09 | -0.03% |
| 31 de marzo de 2026 | $-0.04 | $-0.07 | 0.03% |
| 31 de diciembre de 2025 | $0.05 | $0.06 | -0.01% |
| 30 de septiembre de 2025 | $0.08 | $0.03 | 0.05% |
| 30 de junio de 2025 | $0.02 | $0.03 | -0.01% |
| 31 de marzo de 2025 | $0.03 | $0.03 | -0.00% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Balance general 27
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Flujo de Efectivo 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Tasas de Crecimiento 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | -177,045,292 | 90,850,040 | 89,119,344 | 86,420,530 | -169,316,980 | 85,643,646 | 85,502,403 | 83,265,879 | -124,932,682 | 63,588,119 | 63,588,119 | 63,588,119 | -30,829,566 | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | -205,463,888 | 103,971,546 | 89,203,138 | 101,970,672 | -205,146,932 | 102,640,373 | 102,205,888 | 102,594,197 | -170,898,339 | 78,904,324 | 78,904,324 | 78,921,366 | -18,737,151 | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Balance general 25
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Flujo de Efectivo 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $102M | · | $105M | $100M | $100M | · | $110M | $114M | $113M | · | · | · | · | · | $6M | |
| Net Income TTM | $-29M | $1M | · | $14M | $13M | $21M | · | $25M | $26M | $25M | · | $11M | $55M | $36M | · | $7M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -99.6 | · | 186.5 | 367.5 | 154.4 | · | 125.4 | 108.5 | 134.5 | · | -120.0 | 3.4 | 3.0 | · | 34.1 | |
| P/S | · | 6.2 | · | 6.5 | 6.7 | 6.8 | · | 9.8 | 9.0 | 13.2 | · | · | · | · | · | 41.5 | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| P / FCF | · | 212.1 | · | · | · | -2695.4 | · | · | · | 562.8 | · | · | · | · | · | · | |
| Earnings Yield | -3.3% | -1.0% | · | 0.54% | 0.27% | 0.65% | · | 0.80% | 0.92% | 0.74% | · | -0.83% | 29.1% | 33.3% | · | 2.9% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $117M | $106M | $113M | $102M | $7M |
| Margen Bruto % | — | 96.3% | 95.9% | — | — |
| Margen Operativo % | 9.8% | 15.3% | -59.3% | — | — |
| Beneficio neto | $10M | $18M | $-85M | $4M | $-88M |
| EPS Diluido | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 5.6 | 3.3 | 2.9 | 1.7 | — |
| Ratio Rápido | 4.6 | 2.4 | 1.7 | 1.3 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-180.0K | $-6M | $17M | — | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 63 declarantes · $55.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 17 (+6 vs trimestre anterior) | 7 (+4 vs trimestre anterior) | 26 (+8 vs trimestre anterior) | 8 (0 vs trimestre anterior) | +6.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| HSG Holding Ltd | $24 714 470 | 3 750 299 | 44,65% | Acciones |
| VANGUARD GROUP INC | $7 437 901 | 1 053 527 | 13,44% | Acciones |
| Octagon Capital Advisors LP | $6 289 601 | 954 416 | 11,36% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $5 778 949 | 876 927 | 10,44% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 006 906 | 456 126 | 5,43% | Acciones |
| STATE STREET CORP | $1 617 199 | 245 402 | 2,92% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 214 445 | 184 286 | 2,19% | Acciones |
| SBI Securities Co., Ltd. | $1 098 883 | 166 750 | 1,99% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $995 571 | 151 073 | 1,80% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816 850 | 123 953 | 1,48% | Acciones |
| GOLDMAN SACHS GROUP INC | $568 289 | 86 235 | 1,03% | Acciones |
| Bank of New York Mellon Corp | $227 935 | 34 588 | 0,41% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $171 392 | 24 590 | 0,31% | Acciones |
| STRS OHIO | $170 022 | 25 800 | 0,31% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $161 521 | 24 510 | 0,29% | Acciones |
| Nuveen, LLC | $161 488 | 24 505 | 0,29% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $121 836 | 18 488 | 0,22% | Acciones |
| RHUMBLINE ADVISERS | $111 131 | 16 865 | 0,20% | Acciones |
| FMR LLC | $98 679 | 14 974 | 0,18% | Acciones |
| BANK OF AMERICA CORP /DE/ | $82 539 | 12 525 | 0,15% | Acciones |
| Polymer Capital Management (US) LLC | $77 630 | 11 780 | 0,14% | Acciones |
| Vanguard Global Advisers, LLC | $65 788 | 9 983 | 0,12% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $59 382 | 9 011 | 0,11% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55 659 | 8 446 | 0,10% | Acciones |
| CITIGROUP INC | $49 603 | 7 527 | 0,09% | Acciones |
| BlackRock, Inc. | $28 752 | 4 363 | 0,05% | Acciones |
| Russell Investments Group, Ltd. | $23 803 | 3 612 | 0,04% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $22 973 | 3 486 | 0,04% | Acciones |
| NORTHERN TRUST CORP | $18 887 | 2 866 | 0,03% | Acciones |
| BARCLAYS PLC | $18 558 | 2 816 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $17 793 | 2 700 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $16 271 | 2 469 | 0,03% | Acciones |
| MORGAN STANLEY | $16 106 | 2 444 | 0,03% | Acciones |
| Legal & General Group Plc | $13 536 | 2 054 | 0,02% | Acciones |
| Ameritas Investment Partners, Inc. | $4 501 | 683 | 0,01% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 454 | 639 | 0,01% | Acciones |
| ROYAL BANK OF CANADA | $4 000 | 537 | 0,01% | Acciones |
| Activest Wealth Management | $3 512 | 533 | 0,01% | Acciones |
| Arax Advisory Partners | $1 621 | 246 | 0,00% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $1 285 | 195 | 0,00% | Acciones |
| Sterling Capital Management LLC | $1 061 | 161 | 0,00% | Acciones |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Acciones |
| CWM, LLC | $725 | 104 | 0,00% | Acciones |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Acciones |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $435 | 66 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $361 | 56 | 0,00% | Acciones |
| GoalVest Advisory LLC | $330 | 50 | 0,00% | Acciones |
| Allworth Financial LP | $251 | 38 | 0,00% | Acciones |
| DEUTSCHE BANK AG\ | $244 | 37 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $216 | 33 | 0,00% | Acciones |
| UBS Group AG | $165 | 25 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $100 | 15 031 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $99 | 15 | 0,00% | Acciones |
| Integrated Wealth Concepts LLC | $94 | 14 | 0,00% | Acciones |
| EverSource Wealth Advisors, LLC | $53 | 8 | 0,00% | Acciones |
| Farther Finance Advisors, LLC | $53 | 8 | 0,00% | Acciones |
| Optiver Holding B.V. | $40 | 6 | 0,00% | Acciones |
| Smartleaf Asset Management LLC | $39 | 6 | 0,00% | Acciones |
| State of Alaska, Department of Revenue | $34 | 5 219 | 0,00% | Acciones |
| ROTHSCHILD INVESTMENT LLC | $7 | 1 | 0,00% | Acciones |
| Essential Partners LLC | $7 | 1 | 0,00% | Acciones |
| Covestor Ltd | $0 | 48 | 0,00% | Acciones |
Informantes de la empresa 66 insiders · 26 directivos · 32 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 8 de junio de 2026 A | 2 565 226 | 0 | 2 | $-82 927 |
| Han Ying | Chief Executive Officer | 14 de agosto de 2024 A | — | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 de noviembre de 2023 A | — | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 4 de mayo de 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 4 de mayo de 2026 A | 15 000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 7 de enero de 2026 A | — | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 de agosto de 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 8 de febrero de 2021 A | — | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 de agosto de 2019 A | 3 744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 de agosto de 2015 A | 1 159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 de octubre de 2014 A | 57 799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 de mayo de 2025 S | 2 806 084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 de junio de 2026 M | 700 000 | 0 | 16 | $-869 947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 8 de junio de 2026 A | — | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 9 de agosto de 2022 P | 9 417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 9 de agosto de 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 de marzo de 2020 P | 7 353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 de octubre de 2015 A | 31 008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 de agosto de 2015 A | 45 000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 de octubre de 2014 A | 46 000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 de enero de 2014 A | — | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 de enero de 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 de enero de 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 de enero de 2013 A | 15 938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 de septiembre de 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 de marzo de 2011 A | 1 153 | 0 | 0 | $0 |
| Claire Weston | Consejero | 3 de agosto de 2026 A | — | 0 | 0 | $0 |
| Maxwell Kirkby | Consejero | 3 de agosto de 2026 A | — | 0 | 0 | $0 |
| Dan Weng | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Ping Zhang | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Rodney L Nussbaum | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Renate Parry | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Gordon Carmichael | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| David M. Epstein | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Nassim Usman | Consejero | 28 de junio de 2024 M | 1 636 | 0 | 0 | $0 |
| Andrea Hunt | Consejero | 31 de agosto de 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Consejero | 31 de agosto de 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Consejero | 7 de enero de 2022 A | 31 790 | 0 | 0 | $0 |
| Eddie Williams | Consejero | 7 de enero de 2022 A | 34 804 | 0 | 0 | $0 |
| Errol B Desouza | Consejero | 1 de octubre de 2021 A | 29 801 | 0 | 0 | $0 |
| Jeanne Y Jew | Consejero | 9 de septiembre de 2021 A | — | 0 | 0 | $0 |
| Sharon Tetlow | Consejero | 9 de junio de 2021 A | 3 635 | 0 | 0 | $0 |
| John P Richard | Consejero | 13 de marzo de 2020 P | 3 716 | 0 | 0 | $0 |
| Stephen A Hill | Consejero | 6 de septiembre de 2018 D | 1 190 | 0 | 0 | $0 |
| Harold E Selick | Consejero | 16 de enero de 2018 A | 16 614 | 0 | 0 | $0 |
| Jeff Himawan | Consejero | 20 de agosto de 2015 J | 1 179 352 | 0 | 0 | $0 |
| Alan W Dunton | Consejero | 14 de agosto de 2015 A | 10 000 | 0 | 0 | $0 |
| Charles A Blixt | Consejero | 14 de agosto de 2015 A | 10 000 | 0 | 0 | $0 |
| Julia R Brown | Consejero | 14 de agosto de 2015 A | 10 000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Consejero | 7 de junio de 2013 A | 11 332 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 21 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 7 de mayo de 2026 | 6,33% | Enmienda | — | SEC |
| Ying Luo, Ping Lan | 6 de mayo de 2026 | 8,60% | Enmienda | — | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 presentaciones | 6 de mayo de 2026 | 69,10% | Enmienda | — | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 6 de septiembre de 2024 | — | Presentación inicial | — | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 6 de septiembre de 2024 | — | Presentación inicial | — | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 presentaciones | 31 de octubre de 2023 | — | Presentación inicial | — | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 presentaciones | 7 de octubre de 2022 | — | Presentación inicial | — | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 presentaciones | 22 de septiembre de 2022 | — | Presentación inicial | — | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 presentaciones | 27 de enero de 2022 | — | Presentación inicial | — | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 presentaciones | 5 de agosto de 2020 | — | Presentación inicial | — | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 presentaciones | 17 de enero de 2020 | — | Presentación inicial | — | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 de febrero de 2018 | — | Presentación inicial | — | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 presentaciones | 9 de febrero de 2018 | — | Presentación inicial | — | SEC |
| 23 de mayo de 2017 | — | Presentación inicial | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 presentaciones | 29 de marzo de 2017 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 18 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWO · iShares Trust | 0,01% | 117 803 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 386 378 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 5 185 NS | 30 de abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 99 892 NS | 31 de mayo de 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 41 237 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,00% | 555 NS | 31 de mayo de 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 435 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 441 NS | 31 de mayo de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1 907 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 11 NS | 31 de mayo de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18 000 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 238 693 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 614 654 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 104 607 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 047 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13 494 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 805 SH | 8 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 30 de abril de 2026 | N-PORT |